Navigating the Future: COVID-19 Current Therapy Market Trends and Forecast Insights, 2025 Edition

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the COVID-19 Current Therapy Market Size By 2025?
The market size for present COVID-19 therapies has seen a sharp fall in the past few years. It is projected to plummet from "$5.87 billion in 2024 to $2.35 billion in 2025, reflecting a compound annual growth rate (CAGR) of -60.0%. This reduction in the historic period could be due to factors like limited available treatments, inconsistent treatment effectiveness, supply chain interruptions, fast-developing scientific understanding, and the appearance of new variants.

View the full report here:
https://www.thebusinessresearchcompany.com/report/coronavirus-current-therapy-global-market-report

Which Key Market Drivers Powering COVID-19 Current Therapy Market Expansion and Growth?
The global pandemic COVID-19 has played a major role in the expansion of the COVID-19 current therapy market. The World Health Organization (WHO) announced the pandemic's global status. It was reported in August 2022 by the WHO, a specialized branch of the United Nations based in Switzerland, that the global number of COVID-19 cases had hit 581.8 million. With no specific drug yet officially approved for COVID-19, the need has dramatically increased for repurposed drugs to be used in treating the virus. Drug shortages are being experienced worldwide, leading drug manufacturers to boost their production to fulfill the international demand. The FDA has launched the COVID-19 Treatment Acceleration Program (CTAP) which is a special emergency project aimed at fast-tracking the development and distribution of potential COVID-19 therapies.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3247&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the COVID-19 Current Therapy Market?
Convalescent Plasma Therapy, an experimental treatment method, is being used on COVID-19 patients. Convalescent plasma or CP refers to the blood plasma from individuals who have fully recovered from an illness. This therapy falls under the classification of passive antibody therapy where blood plasma from those recovered from a specific illness is isolated and given to patients who have severe forms of the same illness to mitigate harshness and improves clinical signs. It is noted that the blood plasma of individuals who have recovered from COVID-19 carries antibodies that combat the disease. The FDA recommends Convalescent Plasma Therapy as a research product during public health crises. A total of 2,004 sites, following a single expanded access protocol by the US FDA, had been noted as participants, and among these, 7,744 patients were marked for participation, with 3,809 individuals having already been treated via convalescent plasma transfusion. If enough data backs the results, this experimental therapy is expected to attract greater interest.

What Are the Emerging Segments in the COVID-19 Current Therapy Market?
The COVID-19 current therapy market covered in this report is segmented -

1) By Drug Type: Antiviral, Monoclonal Antibodies, Corticosteroid, Supplements, Antimalarial, Interferons And Interleukin Inhibitors, Other Anti-Infective Drugs, Others
2) By Route Of Administration: Oral, Intravenous
3) By End-User: Hospitals, Clinics, Home Care, Others

Subsegments:
1) By Antiviral: Remdesivir, Oseltamivir, Favipiravir, Nirmatrelvir Or ritonavir (Paxlovid)
2) By Monoclonal Antibodies: Bamlanivimab, Casirivimab Or Imdevimab (REGEN-COV), Sotrovimab, Etesevimab
3) By Corticosteroid: Dexamethasone, Hydrocortisone, Prednisone
4) By Supplements: Vitamin D, Vitamin C, Zinc, Quercetin
5) By Antimalarial: Hydroxychloroquine, Chloroquine
6) By Interferons and Interleukin Inhibitors: Interferon beta-1a, Interleukin-6 inhibitors
7) By Other Anti-Infective Drugs: Antibiotics, Antifungal agents
8) By Others: Other experimental therapies, Alternative treatments not categorized above

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=3247&type=smp

Who Are the Global Leaders in the COVID-19 Current Therapy Market?
Major companies operating in the COVID-19 current therapy market include Gilead Sciences, Inc., Ipca Laboratories Limited, Zydus Cadila, Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, AbbVie, Glenmark Pharmaceuticals Limited, Eli Lilly and Company, Wallace Pharmaceuticals, Inc., Mylab Discovery Solutions, Kalbe Farma, He Qi Group Foundation, Beijing Jinwofu Bioengineering Technology Company, Zhejiang Orient Gene Biotech Co. Ltd, Transasia Bio Medicals, Vanguard Diagnostics, HLL Lifecare Limited, Voxtur Bio Ltd, Biocryst Pharma, Clover Biopharmaceuticals, Inovio Pharmaceuticals, Inc., LAB-CARE Diagnostics, ImmunoScience, CPC Diagnostics, Sysmex Corporation, Atomo Diagnostics, Cellmid Limited, Moderna Therapeutics, Novavax, Bravovax, Ascletis Pharma, Altimmune, Hunan Lituo Biotechnology, Hangzhou Biotest Biotech, AmonMed Biotechnology, Getein Biotech, Beijing Tigsun Diagnostics, Vivacheck Lab, Seegene, SD Biosensor, Fujirebio, Siemens Healthcare Pte. Ltd., Senova, LetsGetChecked, Omega Diagnostics, Abingdon Health, Babylon, Motologic, F. Hoffmann-La Roche Ltd., Novacyt Group, AstraZeneca, Pfizer, Zentiva, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi, Amgen and AdaptiveBiotechnologies, BioNtech, Cytodyn, Heat biologics, Johnson&Johnson, Takeda pharmaceuticals, Vaxart, Vir Biotechnology, Victory Square Health, Abbott Molecular Inc., ACRO Biotech, Advagen Biotech Ltd, BD, Boditech Med, Inc., Cellex Inc., CerTest Biotec, S.L., Hi Technologies, BATM, BioMedomics Quant Lease, CapeBio, Astel Diagnostics, Canary Health Technologies, Thermo Fisher Scientific

Which are the Top Profitable Regional Markets for the COVID-19 Current Therapy Industry?
North America is the largest region in the COVID-19 current therapy market in 2024. Middle East is expected to be the fastest-growing region in the global COVID-19 current therapy market share during the forecast period. The regions covered in the COVID-19 current therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3247

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.